Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Apr 5;17(1):2332872.
doi: 10.1080/20523211.2024.2332872. eCollection 2024.

Academia-pharmaceutical industry linkage: An academic perspective

Zobia Mubarak  1 , Nasir Abbas  1 , Furqan Khurshid Hashmi  2 , Syed Zia Husnain  2 , Nadeem Irfan Bukhari  1
Affiliations

Academia-pharmaceutical industry linkage: An academic perspective

Zobia Mubarak et al. J Pharm Policy Pract. .

Abstract

Background: The pharmaceutical sector in Pakistan has grown over a period, however, there are several barriers in the framework governing the growth of the country's pharmaceuticals. The lack of academia-industry linkage (AIL) is among the critical barriers; hence the focus of the study is to find out the reasons for the lack in the above collaboration. Understanding barriers may help their redressal.

Method: This qualitative phenomenology-based study has been conducted in the most prominent pharmacy institutes, located in Lahore, Islamabad, Peshawar, Sargodha, and Quetta. Academic participants, with a minimum experience of 10 years and designation of assistant professor or above were recruited with a two-stage selection process, purposive sampling and snowball sampling. The data were collected using semi-structured interviews with academic experts. Thematic content analysis was employed to conclude the data.

Results: Analysis of data yielded 8 themes with 18 codes. The main reasons for neglected AIL were explained by a partial or complete lack of industrial research and development activities. Other key factors for the scarcity of AILs were the lack of positive attitude from both industry and academia, applied research in academics, and the research and development of the new molecules in the pharmaceutical industry. Support by the government and the drug regulatory authority of Pakistan in terms of regulatory and academic policies was also perceived to be absent. New horizons in research and development could be opened by providing applied research to industry, including but not limited to new molecule development.

Conclusion: Academia-industry linkage could be boosted with government-backed funded projects and policies. Academia should focus on the industrial-demanded applied research.

Keywords: Pharmaceutical industry; pharmaceutical academia; research and development.

PubMed Disclaimer

Conflict of interest statement

No potential conflict of interest was reported by the author(s).

Figures

Figure 1.
Figure 1.
Schematics for study.
Figure 2.
Figure 2.
The challenges, barriers, facilitators and benefits of pharmacy academia-industry linkages.
See this image and copyright information in PMC

References

    1. Aamir, M., & Zaman, K. (2011). Review of Pakistan pharmaceutical industry: SWOT analysis. International Journal of Business Information Technology, 1(1), 114–117.
    1. Ahmed, A., Chakraborty, D., & Bhattacharyya, R. (2020). The recent coronavirus (COVID-19) pandemic: A review of issues for Indian pharmaceutical exports. Foreign Trade Review, 55(3), 418–435. 10.1177/0015732520926329 - DOI
    1. Alice, L. (2007). Knowledge networks and careers: Academic scientists in industry–university links. Journal of Management Studies, 44(6), 993–1016.
    1. Anand, O., Yu, L. X., Conner, D. P., & Davit, B. M. (2011). Dissolution testing for generic drugs: An FDA perspective. The AAPS Journal, 13(3), 328–335. 10.1208/s12248-011-9272-y - DOI - PMC - PubMed
    1. Attarwala, F. S. (2021). Why our drug market is askew. DAWN. https://www.dawn.com/news/1615251.

LinkOut - more resources